Literature DB >> 2436087

Observations on the actions of substance P and [D-Arg1,D-Pro2,D-Trp7,9,Leu11)substance P on single neurons of the guinea pig submucous plexus.

A Surprenant, R A North, Y Katayama.   

Abstract

Intracellular recordings were made from neurons of the guinea pig submucosal plexus and the effects of substance P and the substance P analogue [D-Arg1,D-Pro2,D-Trp7,9,Leu11]substance P were examined. Substance P (20-200 nM) depolarized all submucosal neurons; these depolarizations were shown to be due to a decrease in the resting (or "leak") potassium conductance of the membrane. In approximately 50% of the 46 neurons tested, superfusion with [D-Arg1,D-Pro2,D-Trp7,9,Leu11]substance P (0.2-20 microM) produced a dose-dependent membrane hyperpolarization. This hyperpolarization was prevented by the alpha 2-adrenoceptor antagonist idazoxan (300 nM) or by concentrations of cobalt which abolished all spontaneous and evoked synaptic potentials, indicating that it resulted from release of noradrenaline from sympathetic nerve terminals. [D-Arg1,D-Pro2,D-Trp7,9,Leu11]substance P depressed the amplitude of the three synaptic potentials recorded from submucosal neurons; the concentrations that caused 50% of the maximal inhibition of the fast excitatory postsynaptic potential, the inhibitory postsynaptic potential, and slow excitatory postsynaptic potential were 40 microM, 600 nM and 20 microM, respectively. When idazoxan was present, the substance P analogue was less effective in depressing the amplitudes of the fast and slow excitatory synaptic potentials suggesting that much of its presynaptic inhibition also resulted from release of noradrenaline. These results provide evidence that [D-Arg1,D-Pro2,D-Trp7,9,Leu11]substance P releases noradrenaline from sympathetic nerves in the submucosal plexus. One effect of this is a membrane hyperpolarization; another is a presynaptic inhibition of transmitter release. These actions much limit the usefulness of this "substance P antagonist" in efforts to show that synaptic potentials, such as the slow excitatory synaptic potential, are mediated by substance P.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436087     DOI: 10.1016/0306-4522(87)90011-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Effects of tachykinins on myenteric neurones of the guinea-pig gastric corpus: involvement of NK-3 receptors.

Authors:  M Schemann; H Kayser
Journal:  Pflugers Arch       Date:  1991-12       Impact factor: 3.657

2.  Pharmacological properties of a C-fibre response evoked by saphenous nerve stimulation in an isolated spinal cord-nerve preparation of the newborn rat.

Authors:  J C Nussbaumer; M Yanagisawa; M Otsuka
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  The effect of substance P on nerve action potential propagation and cholinergic transmission in the myenteric plexus of the guinea-pig ileum.

Authors:  J Sevcik; O Kadlec; I Seferna
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

4.  Substance P mediates synaptic transmission between rat myenteric neurones in cell culture.

Authors:  A L Willard
Journal:  J Physiol       Date:  1990-07       Impact factor: 5.182

5.  Common ionic mechanisms of excitation by substance P and other transmitters in guinea-pig submucosal neurones.

Authors:  K Z Shen; A Surprenant
Journal:  J Physiol       Date:  1993-03       Impact factor: 5.182

6.  Effects of RP 67580, a tachykinin NK1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal rat spinal cord.

Authors:  R Hosoki; M Yanagisawa; J Z Guo; K Yoshioka; T Maehara; M Otsuka
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Contribution of chloride conductance increase to slow EPSC and tachykinin current in guinea-pig myenteric neurones.

Authors:  P P Bertrand; J J Galligan
Journal:  J Physiol       Date:  1994-11-15       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.